Unknown

Dataset Information

0

Immunophenotypic changes in leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia after treatment with CD19-directed chimeric antigen receptor (CAR)- expressing T cells.

ABSTRACT:

SUBMITTER: Mikhailova E 

PROVIDER: S-EPMC8968899 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Immunophenotypic changes in leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia after treatment with CD19-directed chimeric antigen receptor (CAR)- expressing T cells.

Mikhailova Ekaterina E   Illarionova Olga O   Shelikhova Larisa L   Zerkalenkova Elena E   Molostova Olga O   Olshanskaya Yulia Y   Novichkova Galina G   Maschan Alexey A   Maschan Michael M   Popov Alexander A  

Haematologica 20220401 4

Similar Datasets

Unknown Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia.
| S-EPMC7487702 | biostudies-literature
Unknown Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia.
| S-EPMC9851702 | biostudies-literature
Unknown CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity.
| S-EPMC4974466 | biostudies-literature
Unknown CD19 CAR-T expressing PD-1/CD28 chimeric switch receptor as a salvage therapy for DLBCL patients treated with different CD19-directed CAR T-cell therapies.
| S-EPMC7885572 | biostudies-literature
Unknown Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy.
| S-EPMC9004014 | biostudies-literature
Unknown P520: POINT OF CARE CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML) WITH ABERRANT CD19 ANTIGEN EXPRESSION
| S-EPMC10428820 | biostudies-literature
Unknown In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties.
| S-EPMC2572185 | biostudies-literature
Unknown Donor-derived CD19-targeted chimeric antigen receptor T cells in adult transplant recipients with relapsed/refractory acute lymphoblastic leukemia.
| S-EPMC10338536 | biostudies-literature
Unknown A retrospective comparison of CD19 single and CD19/CD22 bispecific targeted chimeric antigen receptor T cell therapy in patients with relapsed/refractory acute lymphoblastic leukemia.
| S-EPMC7572410 | biostudies-literature
Unknown Proteasome inhibition enhances the anti-leukemic efficacy of chimeric antigen receptor (CAR) expressing NK cells against acute myeloid leukemia.
| S-EPMC11406742 | biostudies-literature